1. Home
  2. DFIN vs INDV Comparison

DFIN vs INDV Comparison

Compare DFIN & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DFIN
  • INDV
  • Stock Information
  • Founded
  • DFIN 1983
  • INDV 1994
  • Country
  • DFIN United States
  • INDV United States
  • Employees
  • DFIN N/A
  • INDV N/A
  • Industry
  • DFIN Other Consumer Services
  • INDV Biotechnology: Pharmaceutical Preparations
  • Sector
  • DFIN Consumer Discretionary
  • INDV Health Care
  • Exchange
  • DFIN Nasdaq
  • INDV Nasdaq
  • Market Cap
  • DFIN 1.4B
  • INDV 1.2B
  • IPO Year
  • DFIN N/A
  • INDV N/A
  • Fundamental
  • Price
  • DFIN $44.81
  • INDV $9.52
  • Analyst Decision
  • DFIN Strong Buy
  • INDV Strong Buy
  • Analyst Count
  • DFIN 3
  • INDV 2
  • Target Price
  • DFIN $71.33
  • INDV $14.50
  • AVG Volume (30 Days)
  • DFIN 387.2K
  • INDV 1.1M
  • Earning Date
  • DFIN 04-30-2025
  • INDV 04-24-2025
  • Dividend Yield
  • DFIN N/A
  • INDV N/A
  • EPS Growth
  • DFIN 13.76
  • INDV N/A
  • EPS
  • DFIN 3.06
  • INDV N/A
  • Revenue
  • DFIN $781,900,000.00
  • INDV $1,188,000,000.00
  • Revenue This Year
  • DFIN $4.59
  • INDV N/A
  • Revenue Next Year
  • DFIN $4.40
  • INDV $4.26
  • P/E Ratio
  • DFIN $14.59
  • INDV N/A
  • Revenue Growth
  • DFIN N/A
  • INDV 8.69
  • 52 Week Low
  • DFIN $41.76
  • INDV $7.33
  • 52 Week High
  • DFIN $71.01
  • INDV $22.53
  • Technical
  • Relative Strength Index (RSI)
  • DFIN 38.83
  • INDV 45.90
  • Support Level
  • DFIN $43.20
  • INDV $9.29
  • Resistance Level
  • DFIN $46.51
  • INDV $9.98
  • Average True Range (ATR)
  • DFIN 1.39
  • INDV 0.35
  • MACD
  • DFIN 0.57
  • INDV 0.00
  • Stochastic Oscillator
  • DFIN 64.28
  • INDV 25.84

About DFIN Donnelley Financial Solutions Inc.

Donnelley Financial Solutions Inc is a risk and compliance solutions company. The company provides regulatory filing and deal solutions via its software-as-a-service, technology-enabled services, and print and distribution solutions to public and private companies, mutual funds, and other regulated investment firms. The company operates in four segments: Capital Markets - Software Solutions, Capital Markets - Compliance and Communications Management, Investment Companies - Software Solutions and Investment Companies - Compliance and Communications Management. Its geographical segments are the United States( USA), Europe, Asia, Canada, and others, of which the USA accounts for the vast majority of its total revenue.

About INDV Indivior PLC

Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.

Share on Social Networks: